TPP1 and epilepsy: Because the first symptoms (language delay, epileptic seizures, delay of psychomotor development and ataxia) are non-specific to CLN2 and are sometimes found in children with epilepsy as side effects of anti-seizure medications (ASMs), they are commonly misinterpreted, and diagnosis is often delayed.